Advancements in Geographic Atrophy (GA): Current and Emerging Therapies - Fas Inhibition with ONL1204 for the Treatment of GA Secondary to AMD: Results from a Phase 1b Study
Late breakers - ABBV-RGX-314: A one-time in-office gene therapy for the treatment of diabetic retinopathy and the prevention of DME, PDR & other vision threatening complications